Brändstedt, J., Wangefjord, S., Nodin, B., Eberhard, J., Jirström, K., & Manjer, J. (2014). Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability. BioMed Central.

Brändstedt, Jenny, Sakarias Wangefjord, Björn Nodin, Jakob Eberhard, Karin Jirström, and Jonas Manjer. Associations of Hormone Replacement Therapy and Oral Contraceptives With Risk of Colorectal Cancer Defined By Clinicopathological Factors, Beta-catenin Alterations, Expression of Cyclin D1, P53, and Microsatellite-instability. BioMed Central, 2014.

Brändstedt, Jenny, et al. Associations of Hormone Replacement Therapy and Oral Contraceptives With Risk of Colorectal Cancer Defined By Clinicopathological Factors, Beta-catenin Alterations, Expression of Cyclin D1, P53, and Microsatellite-instability. BioMed Central, 2014.